Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-22

Clinical Trial Update: Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether vasopressin is superior to norepinephrine in managing patients at risk of kidney failure undergoing cardiac surgery wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Scheduled Cardiac Surgery With Extracorporeal Circulation, Vasoplegic Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING